Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Rajat Bose of rajatkbose.com is of the view that one can buy Biocon and TCS and can sell Hindalco Industries.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Raymond and Titan Company and can buy Biocon.
Mitessh Thakkar of miteshthacker.com recommends selling United Breweries and advises buying Biocon, Bharat Forge and Interglobe Aviation.
Rajat Bose of rajatkbose.com recommends buying Biocon, Ajanta Pharma and Ashok Leyland.
Sudarshan Sukhani of s2analytics.com suggests selling ONGC, SRF and Marico.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bajaj Auto and Biocon and can sell Canara Bank and Chennai Petro.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Mindtree, Raymond and Titan Company and can sell NBCC and Reliance Infra.
Ashish Kyal of Waves Strategy Advisors advises buying Delta Corp with a target of Rs 378.
Ashwani Gujral of ashwanigujral.com recommends buying Yes Bank, Indiabulls Housing, ICICI Prudential and Biocon.
Ashwani Gujral of ashwanigujral.com recommends buying KRBL and Dewan Housing Finance and advises selling India Cements.
Adani Ports, UltraTech Cement, and Bharti Airtel, among others, are being tracked by investors on Friday.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Glenmark Pharma and Jain Irrigation Systems and can sell Biocon.
Sudarshan Sukhani of s2analytics.com suggests buying Bharat Forge, Biocon and Shriram Transport Finance.
Idea, Sobha and Biocon, among others, are being tracked by analysts on Monday.
What a dream run it has been for the Indian equity market in 2017 - and who would have thought. If we rewind back and talk about all the gloom and doom that were surrounding us back in December of 2016; demonetisation and impending huge indirect tax reform. Well, the Indian market has comea long way and come on top. In this CNBC-TV18 special show '18 for 18', Prakash Diwan of Altamount Capital gave his top stock ideas for 2018.
Sudarshan Sukhani of s2analytics.com advises buying Biocon, Havells and Maruti Suzuki.
Sandeep Wagle of powermywealth.com suggests buying Biocon and Jet Airways.
Mitessh Thakkar of mitesshthakkar.com recommends buying Sonata Software, United Breweries, SAIL, Aurobindo Pharma and Balrampur Chini.
Sudarshan Sukhani of s2analytics.com expects market to move higher and recommends picking private banks including HDFC Bank and ICICI Bank along with Infosys, HCL Tech, Biocon and Bata India.
Rahul Shah of Motilal Oswal recommends buying Maruti Suzuki, Biocon and Shriram Transport Finance.
Mylan and Biocon said that USFDA approved Mylan’s Ogivri, a biosimilar to Swiss biotech giant Roche's blockbuster cancer drug Herceptin, co-developed with Biocon.
Steel sector is being tracked by Bank of America Merrill Lynch on Monday.
We continue to remain positive as long as 10,000 is sustained on the Nifty and the current correction can be utilised to enter into fresh long positions, says Rahul Sharma, Head – Technical & Derivatives Strategy at Centrum Broking.
Ashwani Gujral of ashwanigujral.com has a buy on Jet Airways with a stop loss of Rs 650, target of Rs 675, a buy on Arvind with a stop loss of Rs 440, target of Rs 465 and a buy on United Spirits with a stop loss of Rs 3350, target of Rs 3500.
Sandeep Wagle of powermywealth.com is of the view that one can buy Biocon and sell Grasim Industries.